Circulating tumor cell (CTC) enumeration (CELLSEARCH), along with measuring lactate dehydrogenase (LDH) as part of a composite biomarker panel, may be a good surrogate for survival in patients with metastatic castration-resistant prostate cancer (mCRPC).
John Schieszer has the latest on the story in today in today’s Medical Minute.
Next post in The Medical Minute
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.